Educational diagram illustrating the Judet-Letournel classification of acetabular fractures using anatomical specimens of the hemipelvis. The visual is divided into two rows: 'Elementary' and 'Associated' fracture types. White lines superimposed on the specimens delineate specific fracture patterns. The 'Elementary' row features five simple patterns: Anterior column (vertical line through the pelvic brim), Anterior wall (localized articular segment), Posterior column (ischiadic notch through obturator foramen), Posterior wall (localized posterior rim), and Transverse (horizontal line bisecting the acetabulum). The 'Associated' row demonstrates complex configurations: Both column, Transverse plus posterior wall, Posterior column plus posterior wall, Anterior column with posterior hemitransverse (a vertical anterior column line joined by a horizontal posterior component), and T-type (a transverse fracture with an additional vertical stem extending through the obturator foramen). This orthopedic diagram serves as a clinical reference for orthopedic surgeons and medical students to understand pelvic trauma morphology and surgical planning.

A pathophysiology diagram illustrating the three-stage process of Type III hypersensitivity. The diagram is divided into three vertical panels: 1) Formation of immune complexes, showing soluble antigens and IgG/IgM antibodies combining with complement C1 protein to form antigen-antibody complexes. 2) Deposition of immune complexes, depicting these complexes settling onto the vascular endothelium (basement membrane). 3) Inflammation-mediated immune complexes, detailing the effector phase. This phase shows the activation of anaphylatoxins (C3a, C4a, C5a) which trigger mast cell/basophil degranulation and the release of histamine, leading to increased vascular permeability. Simultaneously, neutrophils are recruited and bind to the deposited complexes via Fc receptors. This binding induces the release of inflammatory mediators, including reactive oxygen species (ROS) and proteolytic enzymes, ultimately causing localized tissue damage and increased cell permeability in the affected area. The illustration uses standardized BioRender icons to represent cells, receptors, and soluble molecules within a clinical immunology context.

This educational infographic details the Echinococcus multilocularis Ulm Classification for Computed Tomography (EMUC-CT), a standardized system for evaluating hepatic Alveolar Echinococcosis (AE). The diagram is divided into two sections: Primary Morphology and Patterns of Calcification. The left section illustrates five morphological types (I-V) using axial CT cross-sections of the liver. Type I (diffuse infiltrating) and Type II (primarily circumscribed, tumor-like) are sub-categorized by the presence or absence of a cystoid portion. Type III (primarily cystoid) distinguishes between intermediate and widespread involvement, further categorized by solid peripheral portions. Type IV displays small-cystoid, metastasis-like lesions, while Type V represents mainly calcified, inactive lesions. The right panel illustrates six distinct calcification patterns within hepatic lesions: feathery (branching), focal (isolated spots), diffuse (widespread), edge-weighted (peripheral), and central. The classification system is designed to improve diagnostic accuracy and clinical assessment of disease activity in patients with Alveolar Echinococcosis.

This orthopaedic anatomical diagram illustrates the Chiron classification (2004) for femoral head fractures, shown across five categorized types (Type I to Type V). Each type is presented using a dry bone model of the proximal femur from two perspectives: a lateral/oblique view and a frontal view of the femoral head. Fracture lines are demarcated by solid black lines to indicate the morphology and size of the fracture fragments. Type I displays small osteochondral fragments at the superior-lateral aspect. Type II shows a 1/4 head fragment on the anterior-superior surface. Type III demonstrates a 1/3 head fragment extending from superior to posterior. Type IV depicts a vertical fracture dividing approximately 1/2 of the femoral head. Type V illustrates cranial cartilage impaction with multiple intersecting lines across the superior articular surface. The classification is clinically relevant for orthopedic surgeons and residents for determining the severity of femoral head trauma and informing surgical decisions, such as fragment fixation versus excision based on size and location.

A comparative pathophysiology diagram illustrating two mechanisms of mast cell activation and degranulation in hypersensitivity. The top panel depicts 'Allergic (IgE)-mediated hypersensitivity,' showing a multi-step process: initial sensitization where an allergen exposure leads to IgE antibodies binding to Fć̵R1 receptors on a Th2-type effector mast cell, followed by a second exposure where allergen cross-linking of the IgE-Fć̵R1 complex triggers degranulation. The bottom panel depicts 'Non-allergic (pseudoallergic)-mediated hypersensitivity,' highlighting that this pathway does not require prior sensitization. Instead, activation is triggered by direct interaction with Engineered Nanomaterials (ENMs) or anaphylatoxins from the complement system (C3a, C4a, C5a), leading directly to the release of intracellular granules. Visually, mast cells are shown as spherical purple cells with dense internal granules that are expelled into the extracellular space upon activation. The diagram serves as an educational tool to distinguish classic Type I hypersensitivity from direct mast cell triggers relevant to toxicology and immunology.

This pathophysiology diagram illustrates three main mechanisms of vaccine-induced anaphylaxis. The 'Classical' pathway (top left) depicts a Vaccine Allergen cross-linking IgE antibodies bound to FcεR1 receptors on a Basophil or Mast cell, triggering degranulation and the release of Histamine. The 'Alternative or additional' pathway (bottom) shows the Vaccine Allergen interacting with IgG antibodies bound to FcγRs on a Neutrophil, resulting in the release of PAF (Platelet-Activating Factor), ROS (Reactive Oxygen Species), proteases, and the formation of NETs (Neutrophil Extracellular Traps). The third section, 'Other mechanisms' (top right), describes non-IgE-mediated Mast cell activation through complement components C3a and C5a receptors, or direct activation of the MRGPRX2 receptor by the vaccine allergen, also leading to histamine release. All three pathways converge on a central axis culminating in Anaphylaxis. The diagram is designed for clinical immunology education, highlighting the diverse cellular and molecular drivers of hypersensitivity reactions.

This pathophysiology diagram illustrates the biological mechanism of local allergic reactions induced by sublingual immunotherapy tablets (SLIT-T). The process begins with the release of allergens from SLIT-T into the oral epithelia. These allergens cross the epithelial barrier and bind to IgE antibodies complexed with FcεRI receptors on the surface of mast cells and basophils. This cross-linking triggers mast cell degranulation, releasing preformed granule mediators such as histamine and bradykinin. Simultaneously, it stimulates basophils to produce newly generated mediators, including platelet-activating factor (PAF), leukotrienes, and prostaglandins. The flowchart then maps these inflammatory mediators to their downstream physiological effects: nerve activation, increased vascular permeability, and vasodilation. Finally, the diagram lists the resulting clinical symptoms, such as pruritus, angioedema, irritation, sneezing, nasal congestion, and rhinorrhea. This educational resource summarizes the Type I hypersensitivity response specific to the sublingual route of allergen administration.

This composite clinical photograph displays the results of dermatological patch testing for Type IV delayed hypersensitivity reactions. Image A is a close-up of a positive nickel patch test, showing a well-demarcated, erythematous, and slightly edematous circular plaque on the skin, characteristic of allergic contact dermatitis. Image B provides a posterior view of a patient's back, illustrating a comprehensive patch test series arranged in a standardized grid-like pattern. Most test sites show only faint rectangular impressions from the adhesive chambers; however, a prominent positive reaction is visible in the lower left quadrant of the grid, appearing as a localized, raised erythematous patch. These images demonstrate the clinical manifestation of cell-mediated immune responses to specific allergens, such as gold and nickel, which are used to diagnose systemic or contact-related allergic reactions in patients presenting with drug exanthems or nonspecific urticaria.

This pathophysiology diagram illustrates the two phases of a Type IV delayed hypersensitivity reaction in the skin: sensitization and elicitation. On the left, the 'Sensitization phase' shows haptens (small red circles) being captured by a cutaneous dendritic cell (DC), represented as a blue star-shaped cell. An arrow indicates the migration of this DC into a draining lymph node, where it presents the antigen to induce specific effector cells. On the right, the 'Elicitation phase' depicts a subsequent exposure under the epidermis (shown as cuboidal cells). Re-exposure triggers dendritic cell activation and the recruitment of CD8+ T cells and lymphocytes. Key molecular markers involved in the acceleration of inflammation are highlighted, including TARC (thymus and activation-regulated chemokine) and elevated IFN-γ (interferon-gamma). The diagram serves as an educational model for understanding the immune mechanisms behind allergic drug eruptions and contact dermatitis, emphasizing the progression from initial antigen recognition in lymph nodes to the localized cytotoxic inflammatory response in peripheral tissues.

This clinical photograph consists of a side-by-side comparison of two skin sections demonstrating a Type IV delayed hypersensitivity reaction following a patch test with acrylic resin. The left image shows an acute-to-subacute phase characterized by diffuse erythema (redness) and fine desquamation (scaling/peeling). Small, scattered inflammatory papules are visible across the surface. The right image depicts a later or more chronic stage of the reaction, where the skin exhibits post-inflammatory hyperpigmentation, appearing darker and brownish. Persistent desquamation and small flakes of skin are evident in both panels, indicating surface texture abnormalities associated with allergic contact dermatitis. The image serves as an educational tool for identifying clinical signs of positive patch test results, specifically in the context of oral lichenoid reactions (OLR) triggered by dental materials like acrylic resin.